Unit 10: Evaluation of Biological Disease Management - Subjective Questions

Laboratory evaluation is the systematic assessment of a biological control agent under controlled in vitro conditions to determine its ability to suppress a plant pathogen.

Major objectives include:

• Screening a large number of microbial isolates rapidly and economically.
• Determining antagonistic activity against the target pathogen.
• Identifying possible mechanisms such as antibiosis, competition, mycoparasitism, lysis, and production of volatile compounds.
• Selecting promising isolates for greenhouse evaluation.
• Determining suitable concentrations, formulations, and application methods.
• Studying compatibility with other disease-management inputs.

Laboratory evaluation is therefore an initial screening stage and does not, by itself, establish field effectiveness.

The dual-culture technique measures the ability of an antagonist to inhibit a fungal pathogen on a common growth medium.

Procedure:

• Pour a suitable sterile medium, commonly potato dextrose agar, into Petri plates.
• Place a mycelial disc of the pathogen near one edge of the plate.
• Place a disc or streak of the antagonist on the opposite side.
• Maintain a pathogen-only plate as the control.
• Incubate the plates under suitable temperature and light conditions.
• Measure radial growth of the pathogen in treatment and control plates.

The percentage inhibition of radial growth is calculated as:

where is inhibition percentage, is pathogen growth in the control, and is pathogen growth in the presence of the antagonist.

A clear inhibition zone may indicate antibiosis, while overgrowth or coiling around pathogen hyphae may indicate mycoparasitism.

The poisoned-food technique evaluates the effect of a bioagent's culture filtrate, extract, or purified metabolite on pathogen growth.

Method:

• Grow the biological control agent in a suitable liquid medium.
• Separate microbial cells from the culture by filtration or centrifugation.
• Add a measured concentration of the sterile culture filtrate or metabolite to molten agar medium.
• Pour the amended medium into sterile Petri plates.
• Place a pathogen disc at the center of each plate.
• Use unamended medium as the control.
• Incubate and record radial growth of the pathogen.

Growth inhibition is determined using:

Interpretation: Greater inhibition indicates stronger activity of non-volatile, diffusible metabolites. Appropriate controls are needed to separate the effects of nutrients, solvents, pH, and microbial metabolites.

Volatile metabolites:

• The pathogen and antagonist are grown in separate agar plates or opposite compartments without direct physical contact.
• The plate bases may be sealed face-to-face so that only airborne metabolites pass between them.
• Pathogen growth is compared with an unexposed control.
• Reduced growth or sporulation indicates activity of volatile organic compounds.

Non-volatile metabolites:

• The antagonist is grown in liquid culture.
• The culture filtrate is sterilized and incorporated into agar at different concentrations.
• The pathogen is inoculated onto the amended medium.
• Radial growth, spore germination, or biomass is measured.

Essential controls include:

• Pathogen-only control.
• Uninoculated-medium filtrate control.
• Solvent control when extracts are used.
• pH-adjusted control.

These assays help distinguish inhibition caused by airborne compounds from inhibition caused by diffusible antibiotics, enzymes, or toxins.

Antibiosis:

• The antagonist produces inhibitory compounds such as antibiotics, toxins, enzymes, or volatile metabolites.
• It may produce a visible inhibition zone in dual culture.
• Culture filtrates may suppress pathogen growth or spore germination.

Competition:

• The antagonist deprives the pathogen of nutrients, space, iron, or infection sites.
• Rapid colonization and siderophore production are common indicators.
• Inhibition may decline when excess nutrients are supplied.

Mycoparasitism:

• A fungal antagonist directly attacks another fungus.
• Microscopic signs include hyphal contact, coiling, penetration, vacuolation, and lysis.
• Hydrolytic enzymes such as chitinases and -1,3-glucanases may be involved.

These mechanisms can operate together, so multiple assays and microscopic observations are required before assigning a specific mode of action.

Procedure:

• Prepare a standardized spore suspension of the target pathogen.
• Prepare a suspension, cell-free filtrate, or metabolite solution of the biological control agent.
• Mix equal or predetermined volumes of the pathogen suspension and test treatment.
• Place droplets on sterile cavity slides, glass slides, or agar-coated plates.
• Include a pathogen suspension mixed with sterile water or buffer as the control.
• Incubate under suitable humidity and temperature.
• Examine a fixed number of spores microscopically and record germinated spores.

Spore germination is calculated as:

where is germination percentage, is the number of germinated spores, and is the total number of spores observed.

Inhibition is calculated by comparing treatment germination with control germination. Germ-tube length, deformation, bursting, and lysis may also be recorded.

Experimental controls establish the cause of an observed response. A pathogen-only control shows normal pathogen growth, while medium, solvent, pH, heat-killed-cell, or commercial-standard controls help identify specific treatment effects.

Replication estimates experimental variation and increases the reliability of treatment means. Each treatment should generally have at least three independent replicates, and the complete experiment should preferably be repeated.

Randomization prevents systematic bias caused by differences in shelf position, temperature, light, incubation time, or handling. Plates should be randomly assigned to positions and periodically rearranged when appropriate.

A sound laboratory experiment also requires:

• Uniform inoculum size and age.
• Standardized medium and incubation conditions.
• Consistent observation times.
• Blinded or objective measurements where possible.
• Statistical analysis of the results.

Without these practices, apparent antagonism may be caused by uncontrolled variation rather than the biological treatment.

Let represent radial growth of the pathogen in the untreated control and represent growth in the treatment.

The reduction caused by the treatment is:

To express this reduction as a fraction of normal growth:

Multiplying by gives percentage inhibition:

Given mm and mm:

Therefore, the biological treatment produces 60% inhibition of radial growth. This result indicates substantial in vitro suppression, but greenhouse testing is still required because laboratory inhibition does not necessarily predict disease control on plants.

Lytic-enzyme evaluation:

• The bioagent is grown on a medium containing a specific substrate.
• Colloidal chitin is used for detecting chitinase, while laminarin or related glucans may be used for -1,3-glucanase.
• A clear zone around the colony indicates substrate degradation.
• Enzyme activity can also be quantified spectrophotometrically by measuring released products.

Siderophore evaluation:

• Chrome azurol S agar is commonly used.
• A color change around the colony indicates removal of iron from the dye complex by siderophores.
• The diameter of the colored zone can provide a semi-quantitative estimate.
• Liquid assays may quantify siderophore units more precisely.

Significance:

• Lytic enzymes may damage pathogen cell walls and support mycoparasitism.
• Siderophores bind iron and make it less available to pathogens.

These traits provide evidence of possible mechanisms, but they should be related to direct pathogen inhibition and disease reduction assays.

In vitro assays provide rapid and controlled screening, but they have several limitations:

• Artificial media may contain more nutrients than soil or plant surfaces.
• Direct contact in a Petri plate may not occur in the rhizosphere or phyllosphere.
• Temperature, humidity, pH, and light are more variable around plants.
• Native microorganisms may compete with, inhibit, or support the introduced bioagent.
• Plant defense responses are absent from most laboratory assays.
• Root exudates and plant metabolites can alter microbial activity.
• A large inhibition zone may result from antibiotic production that is weak or unstable in soil.
• Some effective agents act mainly through induced resistance and may appear weak in dual culture.
• Formulation, survival, colonization, and application timing are not adequately assessed in vitro.

Therefore, laboratory screening should be followed by greenhouse and field evaluation using living plants and realistic application methods.

Greenhouse evaluation is the testing of biological disease-management treatments on plants grown under controlled or semi-controlled environmental conditions and exposed to a target pathogen.

It is necessary because it evaluates interactions among the host plant, pathogen, biological control agent, growing medium, and environment. Unlike a laboratory assay, it can determine whether a bioagent can:

• Survive and establish on plant surfaces or in the rhizosphere.
• Colonize the required infection site.
• Reduce disease incidence and severity.
• Promote plant growth or cause phytotoxicity.
• Perform under different temperatures, humidity levels, and soil conditions.
• Remain effective when applied as a seed treatment, root dip, soil drench, or foliar spray.

Greenhouse evaluation serves as an intermediate stage between in vitro screening and field trials.

A suitable greenhouse experiment should include the following components:

Treatments:

• Healthy control: plant without pathogen or bioagent.
• Pathogen control: plant inoculated with the pathogen only.
• Bioagent control: plant treated with the bioagent only.
• Bioagent plus pathogen treatment.
• Chemical or registered biological standard, where appropriate.
• Multiple bioagent doses or application timings if required.

Experimental procedure:

• Use uniform seed, seedlings, pots, and growing medium.
• Prepare standardized pathogen and bioagent inocula.
• Apply the bioagent by seed coating, root dip, soil amendment, or drenching.
• Inoculate the pathogen at a defined concentration and time.
• Arrange pots in a completely randomized design or randomized complete block design.
• Use adequate replication and repeat the experiment.
• Maintain recorded temperature, moisture, and humidity conditions.

Observations:

• Seed germination and seedling emergence.
• Disease incidence and severity.
• Incubation period and plant mortality.
• Plant height, root length, biomass, and yield-related traits.
• Bioagent population or root-colonization level.

Data should be statistically analyzed to determine whether disease reduction is significant and reproducible.

Disease incidence is the proportion of plants or plant units that show disease symptoms. It does not measure how badly each plant is affected.

where is the number of diseased plants and is the total number of plants assessed.

Disease severity is the amount or extent of plant tissue affected. It may be measured as lesion area, percentage tissue damage, or a numerical rating scale.

When a rating scale is used, the percent disease index can be calculated as:

where is the number of observations and is the maximum rating on the scale.

Incidence is useful for diseases such as damping-off or wilt, while severity provides greater detail for leaf spots, blights, rots, and other diseases that vary in intensity.

The percent disease index, or PDI, converts disease ratings into a percentage:

where is the number of plants or plant parts assessed and is the maximum score on the disease scale.

The percent disease control compares disease in a treatment with disease in the pathogen control:

where is disease incidence or severity in the pathogen control and is the corresponding value in the treatment.

For example, if the pathogen control has a PDI of and the bioagent treatment has a PDI of :

Thus, the treatment provides 60% disease control relative to the pathogen control. The same disease variable and observation date must be used for a valid comparison.

Seed treatment:

• Bioagent cells or formulations are coated onto seeds.
• It protects seeds and emerging roots from seed- and soil-borne pathogens.
• Adhesives may improve retention, but the treatment must not reduce germination.

Seedling root dip:

• Roots are immersed in a bioagent suspension before transplanting.
• It provides direct delivery to the rhizosphere and root surface.
• It is particularly useful against root rots, wilts, and transplanting diseases.

Soil application:

• The bioagent is incorporated into soil or applied as a drench.
• It targets soil-borne pathogens and supports rhizosphere colonization.
• Carrier material, soil moisture, and organic matter strongly affect performance.

Foliar application:

• A bioagent suspension or formulation is sprayed onto aerial plant parts.
• It is used against leaf spots, blights, rusts, and other foliar diseases.
• Coverage, ultraviolet radiation, humidity, rainfastness, and leaf-surface survival are important.

The preferred method should place the bioagent at the infection site before or during pathogen establishment.

Concentration optimization:

• Prepare a series of viable-cell or spore concentrations, such as , , , and colony-forming units per milliliter.
• Apply equal volumes to comparable plants.
• Record disease suppression, plant growth, colonization, and phytotoxicity.
• Identify the lowest concentration that provides consistent and statistically significant control.

Timing optimization:

• Apply the bioagent several days before pathogen inoculation to test preventive activity and establishment.
• Apply it simultaneously with the pathogen to test direct competition.
• Apply it after pathogen inoculation to assess curative or suppressive activity.
• Evaluate repeated applications when persistence is limited.

A factorial design can test concentration and timing together. The optimum schedule should provide effective disease reduction, reliable colonization, no harmful plant effects, and practical use of the product.

Environmental factors:

• Temperature affects growth, sporulation, metabolite production, and survival of both bioagent and pathogen.
• Relative humidity and leaf wetness influence foliar colonization and infection.
• Soil moisture affects microbial movement, oxygen availability, and root disease development.
• Soil pH, texture, salinity, and organic matter influence establishment and nutrient availability.
• Light and ultraviolet radiation affect the survival of foliar bioagents.

Biological factors:

• Host cultivar and growth stage influence susceptibility and root exudation.
• Pathogen inoculum density and aggressiveness determine disease pressure.
• Bioagent strain, physiological age, dose, and formulation affect performance.
• Indigenous microorganisms may compete with or support the introduced organism.
• Root or leaf colonization ability determines whether the bioagent reaches the infection site.

Greenhouse conditions must therefore be monitored and reported so that differences among experiments can be interpreted correctly.

Disease reduction should be evaluated together with plant health because a treatment may promote growth, have no direct growth effect, or cause injury.

Plant-growth measurements include:

• Seed germination and seedling emergence.
• Plant height and number of leaves.
• Root length and root volume.
• Fresh and dry shoot biomass.
• Fresh and dry root biomass.
• Chlorophyll content, flowering, or yield-related traits where relevant.

Phytotoxicity observations include:

• Reduced germination or emergence.
• Chlorosis, necrosis, leaf burn, or deformation.
• Root browning or stunting.
• Delayed growth or abnormal development.

A bioagent-only control is essential because it separates the treatment's direct effects on the plant from its effects on the pathogen. Measurements should be made at fixed times using uniform methods and analyzed statistically.

A completely randomized design is suitable when greenhouse conditions are relatively uniform. A randomized complete block design is preferred when gradients in light, temperature, ventilation, or bench position are expected. Factorial designs can evaluate interactions among bioagent strain, dose, timing, formulation, or cultivar.

Important design features include:

• Adequate independent replication.
• Random assignment of treatments.
• Blocking based on known environmental gradients.
• Uniform experimental units and inoculation procedures.
• Repetition of the experiment over time.

Statistical analysis:

• Analysis of variance can compare treatment means.
• A suitable multiple-comparison procedure can separate means after a significant overall test.
• Generalized linear models may be preferable for binary incidence or count data.
• Percentage data may require an appropriate transformation or binomial model.
• Ordinal disease ratings should be analyzed using methods consistent with their scale.
• Results should include variability measures, effect sizes, and significance levels.

Statistical significance should be interpreted together with biological importance and consistency across experiments.

Laboratory evaluation:

• Conducted under highly controlled conditions.
• Rapid, inexpensive, and suitable for screening many isolates.
• Measures traits such as growth inhibition, antibiosis, enzyme production, and mycoparasitism.
• Has limited representation of plant, soil, and environmental interactions.

Greenhouse evaluation:

• Uses living plants under controlled or semi-controlled conditions.
• Measures disease incidence, severity, plant growth, colonization, and phytotoxicity.
• Tests realistic application methods, doses, and timings.
• Is more costly and variable but more predictive of field performance.

Criteria for advancement to field testing:

• Significant and reproducible disease suppression.
• Effective colonization or persistence at the infection site.
• No phytotoxicity or unacceptable effect on plant growth.
• Performance across relevant environmental conditions and disease pressures.
• Compatibility with practical formulations and application methods.
• Reasonable shelf life, dose, and production feasibility.
• Evidence of safety to plants, humans, animals, and non-target organisms.
• Performance comparable with an accepted standard or sufficient value within integrated disease management.

A candidate should be advanced based on the combined weight of laboratory and greenhouse evidence, not solely on strong in vitro inhibition.